Bristol-Myers Drug Shows Promise for Skin-Cancer Patients

A new Bristol-Myers Squibb Co. drug helped skin-cancer patients live longer than those who received chemotherapy in a clinical trial, the latest evidence behind a promising new crop of drugs that work by unleashing the body’s immune system against tumors.



from WSJ.com: US Business http://ift.tt/1uA9PoA

via IFTTT